了解癌症临床试验参与的财务成本
Courtney P Williams1, Luqin Deng1, Nicole E Caston1
1University of Alabama at Birmingham, Birmingham, Alabama, USA.
Cancer medicine
|April 17, 2024
概括
癌症临床试验中近一半的患者经历了经济困难,主要是由于旅行费用. 这种财务负担减少了加入未来试验的意愿,突出了需要支持性干预的需要.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 患者倡导 患者倡导
背景情况:
- 标准的癌症治疗通常会导致经济困难.
- 对于癌症临床试验参与者的自付费用,人们的了解有限.
- 这项研究调查了参与癌症临床试验的财务影响.
研究的目的:
- 探索与参与癌症临床试验相关的财务影响和自付费用.
- 确定导致试验参与者经济困难的因素.
- 评估经济困难对未来临床试验参与意愿的影响.
主要方法:
- 从2022年12月到2023年5月期间收集的美国癌症成年人的横截面调查数据.
- 对参与癌症临床试验,与试验相关的财务困难和社会人口统计数据的调查答案的分析.
- 描述性统计,Cramer's V用于关联大小,以及调整后相对风险 (aRR) 的修改Poisson回归.
主要成果:
- 在650名受访者中,有18%参与了癌症临床试验;其中47%的人报告了经济困难.
- 与审判相关的财务困难与失业/残疾和更长的旅行距离 (>1小时) 有关.
- 主要支出包括旅行费 (71%),医疗费 (58%),餐费 (40%) 和住房费 (40%). 受访者每月需要200-1000美元.
- 51%的人因困难而不愿意参加未来的试验;13%的人因成本而拒绝参加试验.
结论:
- 经济困难显著影响近一半的癌症临床试验参与者,主要是由旅行费用驱动的.
- 干预对于减轻财务负担和潜在提高癌症临床试验参与率至关重要.
- 解决成本障碍对于通过临床试验公平获得新型癌症疗法至关重要.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Nursing Ethical Principles II
958
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
958
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Hazard Ratio
116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
116
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


